A Nonrandomized, Open-label, Multicenter, Sequential Phase Study to Evaluate the Safety and Efficacy of Cyclosporine Dose Reduction and Cyclosporine Elimination in Chinese De Novo Renal Allograft Recipients Receiving Rapamune.
Phase of Trial: Phase I/II
Latest Information Update: 01 Feb 2011
At a glance
- Drugs Ciclosporin; Sirolimus
- Indications Renal transplant rejection
- Focus Adverse reactions; Therapeutic Use
- Sponsors Wyeth
- 08 Jun 2007 Status changed from in progress to completed.
- 11 May 2007 New trial record.